- Home
- STRO vs MVBF Comparison
STRO vs MVBF Comparison
Compare STRO & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- MVBF
- Stock Information
- Founded
- STRO 2003
- MVBF 1997
- Country
- STRO United States
- MVBF United States
- Employees
- STRO N/A
- MVBF N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- MVBF Major Banks
- Sector
- STRO Health Care
- MVBF Finance
- Exchange
- STRO Nasdaq
- MVBF Nasdaq
- Market Cap
- STRO 292.6M
- MVBF 288.6M
- IPO Year
- STRO 2018
- MVBF N/A
- Fundamental
- Price
- STRO $2.84
- MVBF $21.76
- Analyst Decision
- STRO Strong Buy
- MVBF Buy
- Analyst Count
- STRO 7
- MVBF 2
- Target Price
- STRO $12.14
- MVBF $27.50
- AVG Volume (30 Days)
- STRO 921.2K
- MVBF 28.7K
- Earning Date
- STRO 11-13-2024
- MVBF 10-30-2024
- Dividend Yield
- STRO N/A
- MVBF 3.16%
- EPS Growth
- STRO N/A
- MVBF N/A
- EPS
- STRO N/A
- MVBF 1.41
- Revenue
- STRO $160,955,000.00
- MVBF $140,251,000.00
- Revenue This Year
- STRO N/A
- MVBF N/A
- Revenue Next Year
- STRO N/A
- MVBF $7.90
- P/E Ratio
- STRO N/A
- MVBF $15.03
- Revenue Growth
- STRO 230.90
- MVBF N/A
- 52 Week Low
- STRO $2.45
- MVBF $17.51
- 52 Week High
- STRO $6.13
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- STRO 40.85
- MVBF 54.73
- Support Level
- STRO $2.66
- MVBF $21.15
- Resistance Level
- STRO $2.86
- MVBF $21.82
- Average True Range (ATR)
- STRO 0.25
- MVBF 0.57
- MACD
- STRO -0.01
- MVBF -0.09
- Stochastic Oscillator
- STRO 24.22
- MVBF 46.09
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.